Profile
Dr. Kevin Wu is on the Board of Directors at Chemspec International Ltd.
He received his undergraduate degree from Peking University, an MBA from Temple University (Pennsylvania), and a doctorate degree from Columbia University.
Former positions of Kevin Wu
Companies | Position | End |
---|---|---|
Chemspec International Ltd.
Chemspec International Ltd. Chemicals: SpecialtyProcess Industries Chemspec International Ltd. manufactures chemical products. It makes fluorinated chemicals used for the variety of purposes, including the development of other chemicals, as well as in the manufacture of products such as electronics, pharmaceuticals, and pesticides. Its products are used as building blocks for advanced chemicals or used to enhance the performance of the end products of their clients. Its three major market areas are pharmaceutical, agrochemical industries and electronics. It was founded in 1996 and is headquartered in Shanghai, China. | Director/Board Member | - |
Training of Kevin Wu
The Trustees of Columbia University in The City of New York | Doctorate Degree |
Temple University (Pennsylvania) | Masters Business Admin |
Peking University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Chemspec International Ltd.
Chemspec International Ltd. Chemicals: SpecialtyProcess Industries Chemspec International Ltd. manufactures chemical products. It makes fluorinated chemicals used for the variety of purposes, including the development of other chemicals, as well as in the manufacture of products such as electronics, pharmaceuticals, and pesticides. Its products are used as building blocks for advanced chemicals or used to enhance the performance of the end products of their clients. Its three major market areas are pharmaceutical, agrochemical industries and electronics. It was founded in 1996 and is headquartered in Shanghai, China. | Process Industries |
- Stock Market
- Insiders
- Kevin Wu